These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9753710)

  • 101. The insulin-like growth factor-1 binding protein acid-labile subunit alters mesenchymal stromal cell fate.
    Fritton JC; Kawashima Y; Mejia W; Courtland HW; Elis S; Sun H; Wu Y; Rosen CJ; Clemmons D; Yakar S
    J Biol Chem; 2010 Feb; 285(7):4709-14. PubMed ID: 20007694
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Proline cis/trans-isomerase Pin1 regulates peroxisome proliferator-activated receptor gamma activity through the direct binding to the activation function-1 domain.
    Fujimoto Y; Shiraki T; Horiuchi Y; Waku T; Shigenaga A; Otaka A; Ikura T; Igarashi K; Aimoto S; Tate S; Morikawa K
    J Biol Chem; 2010 Jan; 285(5):3126-32. PubMed ID: 19996102
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Genetic variations in peroxisome proliferator-activated receptor gamma expression affect blood pressure.
    Tsai YS; Xu L; Smithies O; Maeda N
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19084-9. PubMed ID: 19884495
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Single-nucleotide polymorphisms in peroxisome proliferator-activated receptor gamma and their association with plasma levels of resistin and the metabolic syndrome in a South Indian population.
    Haseeb A; Iliyas M; Chakrabarti S; Farooqui AA; Naik SR; Ghosh S; Suragani M; Ehtesham NZ
    J Biosci; 2009 Sep; 34(3):405-14. PubMed ID: 19805902
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Bisphenol A: Perinatal exposure and body weight.
    Rubin BS; Soto AM
    Mol Cell Endocrinol; 2009 May; 304(1-2):55-62. PubMed ID: 19433248
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Endocrine disrupters as obesogens.
    Grün F; Blumberg B
    Mol Cell Endocrinol; 2009 May; 304(1-2):19-29. PubMed ID: 19433244
    [TBL] [Abstract][Full Text] [Related]  

  • 107. PPARγ2 polymorphism and human health.
    He W
    PPAR Res; 2009; 2009():849538. PubMed ID: 19390629
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Minireview: the case for obesogens.
    Grün F; Blumberg B
    Mol Endocrinol; 2009 Aug; 23(8):1127-34. PubMed ID: 19372238
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Genome-wide analysis to predict protein sequence variations that change phosphorylation sites or their corresponding kinases.
    Ryu GM; Song P; Kim KW; Oh KS; Park KJ; Kim JH
    Nucleic Acids Res; 2009 Mar; 37(4):1297-307. PubMed ID: 19139070
    [TBL] [Abstract][Full Text] [Related]  

  • 110. PPARgamma and Agonists against Cancer: Rational Design of Complementation Treatments.
    Veliceasa D; Schulze-Hoëpfner FT; Volpert OV
    PPAR Res; 2008; 2008():945275. PubMed ID: 19043603
    [TBL] [Abstract][Full Text] [Related]  

  • 111. PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents.
    Sainis I; Vareli K; Karavasilis V; Briasoulis E
    PPAR Res; 2008; 2008():436489. PubMed ID: 18779870
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk.
    Sanghera DK; Ortega L; Han S; Singh J; Ralhan SK; Wander GS; Mehra NK; Mulvihill JJ; Ferrell RE; Nath SK; Kamboh MI
    BMC Med Genet; 2008 Jul; 9():59. PubMed ID: 18598350
    [TBL] [Abstract][Full Text] [Related]  

  • 113. PPARgamma and PPARdelta as Modulators of Neoplasia and Cell Fate.
    Glazer RI; Yuan H; Xie Z; Yin Y
    PPAR Res; 2008; 2008():247379. PubMed ID: 18566686
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
    Guilherme A; Virbasius JV; Puri V; Czech MP
    Nat Rev Mol Cell Biol; 2008 May; 9(5):367-77. PubMed ID: 18401346
    [TBL] [Abstract][Full Text] [Related]  

  • 115. PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.
    Minge CE; Robker RL; Norman RJ
    PPAR Res; 2008; 2008():243791. PubMed ID: 18309368
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Obesity: a review of pathogenesis and management strategies.
    Kaila B; Raman M
    Can J Gastroenterol; 2008 Jan; 22(1):61-8. PubMed ID: 18209783
    [TBL] [Abstract][Full Text] [Related]  

  • 117. An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion.
    Barlic J; Murphy PM
    Trends Cardiovasc Med; 2007 Nov; 17(8):269-74. PubMed ID: 18021937
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Genetic contributors to obesity.
    McPherson R
    Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):23A-27A. PubMed ID: 17668084
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Identifying genes for coronary artery disease: An idea whose time has come.
    Roberts R; Stewart AF; Wells GA; Williams KA; Kavaslar N; McPherson R
    Can J Cardiol; 2007 Aug; 23 Suppl A(Suppl A):7A-15A. PubMed ID: 17668082
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis.
    Grün F; Blumberg B
    Rev Endocr Metab Disord; 2007 Jun; 8(2):161-71. PubMed ID: 17657605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.